Table 1 Study Population Characteristics at the Time of Entry
From: Evaluation of Different Combined Regimens in the Treatment of Cholinergic Urticaria
Variable | Group A (92) Mean ± SD (Average) | Group B (77) Mean ± SD (Average) | Group C (82) Mean ± SD (Average) |
|---|---|---|---|
Age, y | 21 ± 5 (16-29) | 23 ± 4 (17-27) | 23 ± 3 (19-29) |
WBC total count | 6600 ± 120 (5100-9200) | 7500 ± 800 (6000-9000) | 7600 ± 960 (5900-10, 600) |
Neutrophil % | 61 ± 5 (52-70) | 60 ± 6 (49-72) | 63 ± 6 (53-74) |
Lymphocyte % | 29 ± 2 (21-40) | 31 ± 6 (19-41) | 31 ± 6 (19-42) |
Eosinophil % | 7 ± 1(5-9) | 7 ± 1(5-8) | 7 ± 1(5-9) |
Monocyte % | 2 ± 1(1-6) | 2 ± 1(0-6) | 1 ± 1(0-5) |
Basophil % | 0 (0-2) | 0 (0-1) | 0 (0-1) |
ESR, mm/h | 9.5 ± 3(4-20) | 9 ± 2(6-12) | 12 ± 5(4-36) |
PCV % | 42 ± 2 (38-44) | 42 ± 2 (40-44) | 42 ± 2 (36-42) |
Platelets number | 172, 000 ± 83, 900 (150, 000-180, 000) | 170, 000 ± 32, 400 (148, 000-175, 000) | 165, 000 ± 9750 (146, 000-177, 000) |